The World Health Organisation (WHO) has chosen other countries ahead of Nigeria in the first round of supply of the Pfizer-BioNTech vaccine. Matshidiso Moeti, WHO regional director for Africa, said Nigeria was overlooked based on certain...
Nigeria on Friday recorded 1,867 new cases, 705 recoveries and eight additional deaths. The spike in new cases was the country’s highest number within a 24-hour period. There are now 107,345 confirmed cases, 84,535 recoveries...
On the last day of the year, Nigeria reported 1031 new cases and another 11 deaths, taking new national totals to 87510 confirmed cases 73713 recoveries and 1289 deaths. There were however 391 recoveries. The 1031...
A New York doctor was diagnosed with the coronavirus four days after he received the first dose of the Pfizer coronavirus vaccine, Ynet reported. The case occurred at Montefiore Hospital in New York. “One of our team...
Scientists at the US Food and Drug Administration endorsed the Covid-19 vaccine developed by Moderna as safe and efficacious on Tuesday, one day after the first doses of a competing vaccine from Pfizer and BioNTech...
New cases dropped by 48 per cent on Monday to 201 after a week of many spikes. Till date there are 73,374 confirmed; 66,314 recoveries and 1,197 deaths. The 201 new cases are reported from 11...
The US Food and Drug Administration has approved the Pfizer BioNTech coronavirus vaccine for emergency use. President Donald Trump says the first vaccinations will take place "in less than 24 hours". The virus has now killed...
Nigeria, on Tuesday, reported 3 deaths and 281 news cases after days of zero fatality. 7,101 samples were tested across the country. To date, 67,838 cases have been confirmed, 63,430 cases have been discharged and 1,176...
Moderna has filled for US and European emergency regulatory approval of its coronavirus vaccine for widespread use. Regulators will look at trial data for the mRNA vaccine and decide if it is safe and effective enough...
AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine using a lower dosage, its chief executive was quoted as saying on Thursday amid questions over the results...